Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 21

1.

Use and Interpretation of Propensity Scores in Aging Research: A Guide for Clinical Researchers.

Kim DH, Pieper CF, Ahmed A, Colón-Emeric CS.

J Am Geriatr Soc. 2016 Oct;64(10):2065-2073. doi: 10.1111/jgs.14253. Epub 2016 Aug 22.

PMID:
27550392
2.

Patterns of Prescription Drug Use Before and After Fragility Fracture.

Munson JC, Bynum JP, Bell JE, Cantu R, McDonough C, Wang Q, Tosteson TD, Tosteson AN.

JAMA Intern Med. 2016 Oct 1;176(10):1531-1538. doi: 10.1001/jamainternmed.2016.4814.

PMID:
27548843
3.

Impact of Age and Sex on Outcomes and Hospital Cost of Acute Asthma in the United States, 2011-2012.

Zein JG, Udeh BL, Teague WG, Koroukian SM, Schlitz NK, Bleecker ER, Busse WB, Calhoun WJ, Castro M, Comhair SA, Fitzpatrick AM, Israel E, Wenzel SE, Holguin F, Gaston BM, Erzurum SC; Severe Asthma Research Program..

PLoS One. 2016 Jun 13;11(6):e0157301. doi: 10.1371/journal.pone.0157301. eCollection 2016 Jun 13.

4.

Examining the Association Between Comorbidity Indexes and Functional Status in Hospitalized Medicare Fee-for-Service Beneficiaries.

Kumar A, Graham JE, Resnik L, Karmarkar AM, Deutsch A, Tan A, Al Snih S, Ottenbacher KJ.

Phys Ther. 2016 Feb;96(2):232-40. doi: 10.2522/ptj.20150039. Epub 2015 Nov 12.

5.

Breast cancer survivorship: a comprehensive review of long-term medical issues and lifestyle recommendations.

Bodai BI, Tuso P.

Perm J. 2015 Spring;19(2):48-79. doi: 10.7812/TPP/14-241. Review.

6.

Serotonin-norepinephrine reuptake inhibitor and selective serotonin reuptake inhibitor use and risk of fractures: a new-user cohort study among US adults aged 50 years and older.

Lanteigne A, Sheu YH, Stürmer T, Pate V, Azrael D, Swanson SA, Miller M.

CNS Drugs. 2015 Mar;29(3):245-52. doi: 10.1007/s40263-015-0231-5.

7.

Older male physicians have lower risk of trochanteric but not cervical hip fractures.

Shen HN, Lin WT, Lu CL, Li CY.

Int J Environ Res Public Health. 2015 Feb 16;12(2):2249-61. doi: 10.3390/ijerph120202249.

8.

Cause or Effect? Selective Serotonin Reuptake Inhibitors and Falls in Older Adults: A Systematic Review.

Gebara MA, Lipsey KL, Karp JF, Nash MC, Iaboni A, Lenze EJ.

Am J Geriatr Psychiatry. 2015 Oct;23(10):1016-28. doi: 10.1016/j.jagp.2014.11.004. Epub 2014 Nov 25. Review.

9.

Measuring frailty using claims data for pharmacoepidemiologic studies of mortality in older adults: evidence and recommendations.

Kim DH, Schneeweiss S.

Pharmacoepidemiol Drug Saf. 2014 Sep;23(9):891-901. doi: 10.1002/pds.3674. Epub 2014 Jun 24. Review.

10.

Rates of bone loss among women initiating antidepressant medication use in midlife.

Diem SJ, Ruppert K, Cauley JA, Lian Y, Bromberger JT, Finkelstein JS, Greendale GA, Solomon DH.

J Clin Endocrinol Metab. 2013 Nov;98(11):4355-63. doi: 10.1210/jc.2013-1971. Epub 2013 Sep 3.

11.

Validation sampling can reduce bias in health care database studies: an illustration using influenza vaccination effectiveness.

Nelson JC, Marsh T, Lumley T, Larson EB, Jackson LA, Jackson ML; Vaccine Safety Datalink Team..

J Clin Epidemiol. 2013 Aug;66(8 Suppl):S110-21. doi: 10.1016/j.jclinepi.2013.01.015.

12.

SSRIs: bad to the bone?

Sansone RA, Sansone LA.

Innov Clin Neurosci. 2012 Jul;9(7-8):42-7.

13.

Antidepressants and fracture risk in older adults: a comparative safety analysis.

Gagne JJ, Patrick AR, Mogun H, Solomon DH.

Clin Pharmacol Ther. 2011 Jun;89(6):880-7. doi: 10.1038/clpt.2011.54. Epub 2011 Apr 20.

14.

Use of antidepressant medications and risk of fracture in older women.

Diem SJ, Blackwell TL, Stone KL, Cauley JA, Hillier TA, Haney EM, Ensrud KE; Study of Osteoporotic Fractures Research Group..

Calcif Tissue Int. 2011 Jun;88(6):476-84. doi: 10.1007/s00223-011-9481-5. Epub 2011 Apr 1.

15.

Use of anti-depressants and the risk of fracture of the hip or femur.

van den Brand MW, Pouwels S, Samson MM, van Staa TP, Thio B, Cooper C, Leufkens HG, Egberts AC, Verhaar HJ, de Vries F.

Osteoporos Int. 2009 Oct;20(10):1705-13. doi: 10.1007/s00198-009-0849-6. Epub 2009 Feb 24. Erratum in: Osteoporos Int. 2009 Oct;20(10):1715.

16.

Assessing residual confounding of the association between antipsychotic medications and risk of death using survey data.

Schneeweiss S, Setoguchi S, Brookhart MA, Kaci L, Wang PS.

CNS Drugs. 2009;23(2):171-80. doi: 10.2165/00023210-200923020-00006.

17.

Depressive symptoms, bone loss, and fractures in postmenopausal women.

Spangler L, Scholes D, Brunner RL, Robbins J, Reed SD, Newton KM, Melville JL, Lacroix AZ.

J Gen Intern Med. 2008 May;23(5):567-74. doi: 10.1007/s11606-008-0525-0. Epub 2008 Feb 20.

18.

Understanding secondary databases: a commentary on "Sources of bias for health state characteristics in secondary databases".

Schneeweiss S.

J Clin Epidemiol. 2007 Jul;60(7):648-50. Epub 2007 Feb 26. No abstract available.

19.

Developments in post-marketing comparative effectiveness research.

Schneeweiss S.

Clin Pharmacol Ther. 2007 Aug;82(2):143-56. Epub 2007 Jun 6. Review.

20.

Readers guide to critical appraisal of cohort studies: 3. Analytical strategies to reduce confounding.

Normand SL, Sykora K, Li P, Mamdani M, Rochon PA, Anderson GM.

BMJ. 2005 Apr 30;330(7498):1021-3. Review. No abstract available.

Supplemental Content

Support Center